Repository logo
Log In
  1. Home
  2. Unibas
  3. Publications
  4. 100 years of Suramin
 
  • Details

100 years of Suramin

Date Issued
2020-01-01
Author(s)
Wiedemar, Natalie  
Hauser, Dennis A.  
Mäser, Pascal  
DOI
10.1128/aac.01168-19
Abstract
Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by; Trypanosoma brucei; rhodesiense; Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, once the polypharmacology of suramin is understood at the molecular level, new, more specific, and less toxic molecules can be identified for the numerous potential applications of suramin.
University of Basel

edoc
Open Access Repository University of Basel

  • About edoc
  • About Open Access at the University of Basel
  • edoc Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement